It will presumably be a double-blind trial so results wouldn’t be known to those conducting it until completion of the trial and all the data exposed.
With only a small number of people in the trial it might not be possible, let alone advisable, to produce, let alone release, any interim data.
We will probably all have to exercise our now well developed patience. At least we have now had a lot of experience developing that patience.
With the small number it does look however that it shouldn’t take too long.
poorinvestor
Ann: Recce Selects CMAX for Phase I/II UTI Clinical Trial, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
-0.005(1.28%) |
Mkt cap ! $111.3M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 38.5¢ | 37.0¢ | $21.54K | 57.86K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3248 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 49884 | 1 |
View Market Depth
| Last trade - 14.27pm 30/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |